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PKA and the Structural Kinome
Abstract
In recognition of the first protein kinase structure that was solved 25 years 
ago, we review the history of the Structural Kinome. What did we learn 
prior to that first structure of the PKA catalytic subunit, what have we 
learned since the structure was solved, and what are our remaining chal-
lenges for the future?
Introduction. Although protein phosphorylation was discovered in 
the 1950’s when casein was found to be a covalently modified phospho-
protein (1), it was not until the classic work of Krebs and Fischer with 
phosphorylase kinase (PhosK) that protein phosphorylation was discov-
ered to be a regulatory mechanism (2). Over the ensuing decades we 
now appreciate that this is one of the major regulatory mechanisms in 
biology and that the eukaryotic protein kinases (EPKs) constitute one 
of the largest families encoded for by the human genome (3). Under-
standing the structure, function, and regulation of these proteins re-
mains as one of the great challenges of the signaling community, and 
the importance of this superfamily is underscored by their therapeutic 
importance as drug targets (4, 5). As we think about the enormous 
complexity of the EPKs, which includes not only large membrane-span-
ning protein kinases such as the epidermal growth factor receptor 
(EGFR) (6) and the insulin receptor (InsR) (7, 8), as well as giant scaf-
fold protein such as Titan (9), but also the multi-component signaling 
complexes such as mTOR (10, 11), it is important to recognize and ap-
preciate the highly dynamic nature of the EPKs. They have evolved from 
the eukaryotic-like kinases (ELKs) (12, 13) to be molecular switches 
that are transiently and dynamically regulated. Their substrates are pro-
teins, not small molecules, and unlike metabolic enzymes such as hexo-
kinase and pyruvate kinase, they have not evolved to be efficient cata-
lysts. In many cases, like MAP kinases (MAPKs), PKCs, and the 
non-receptor tyrosine kinases, dynamic translocation is a critical feature 
of their regulation while in other cases such as the EGFR the kinase 
remains localized to the plasma membrane but can be internalized as 
an endocytotic vesicle with its accessory machinery creating a transient 
signaling organelle (14). What is clear from all of these EPKs, however, 
is that they have not evolved to be efficient catalysts; they have evolved 
to be dynamic and highly regulated molecular switches.
Birth of the Kinome (1959-1979). Cyclic AMP-dependent protein 
kinase (PKA) was the second regulatory protein kinase to be discovered 
nearly a decade after PhosK (15). It was originally found as a contaminant 
of PhosK, and because phosphorylase kinase was its substrate it was 
initially called phosphorylase kinase kinase. The concept of kinase cas-
cades was also thus embedded in those first two kinases where one kinase 
activated another. PhosK is a large multi-subunit kinase (a4b4g4d4) that 
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C-terminus of glycogen phosphorylase (16). Unlike 
PhosK, there are many other targets for PKA in the liver, 
but the fundamental concept of kinase cascades was re-
vealed by these first two protein kinases. With the purifi-
cation of the PKA catalytic (C) subunit (15) and the sub-
sequent discovery of the PKA regulatory (R) subunits 
(17-19), it was quickly renamed cAMP-dependent protein 
kinase. Cyclic GMP-dependent protein kinase (PKG) was 
the next protein kinase to be discovered (20), but unlike 
PKA the cGMP binding domains and the kinase domain 
were part of the same polypeptide chain. PKC came next 
(21) and, like PKG, it contained regulatory domains that 
preceded the kinase domain and also bound to second 
messengers.
Although in those first two decades following the dis-
covery of PhosK and its regulation by protein phosphory-
lation and prior to the discovery of vSrc and cSrc, there 
were only a handful of protein kinases, all exemplified not 
only the switch mechanism but also the importance of 
second messengers, which converged in a variety of ways 
on the protein kinases. Around the same time that Krebs 
and Fischer were discovering protein kinases, Sutherland 
discovered cAMP as a second messenger that was synthe-
sized inside the cell in response to a hormone binding to 
a receptor on the surface of the cell (22). It took two more 
decades for G-proteins to be discovered (23-25). Two of 
the major signaling mechanisms in biology, protein phos-
phorylation and second messenger signaling through 
cAMP, then converged in PKA. This theme of activation 
by a second messenger continued with the discovery of 
cGMP-dependent protein kinase (PKG) in 1970 (20). 
Calcium regulation of protein kinases was introduced first 
by PhosK and glycogen phosphorylase, but it the discov-
ery of PKC by Nishizuka in 1977 and its regulation by 
diacyl glycerol that introduced the concept of lipid second 
messengers (26). In PKC three signaling mechanisms 
converge – protein phosphorylation, calcium signaling 
(27), and lipid second messenger signaling. Myosin light 
chain kinase, discovered in 1977 (28), continued that 
theme of calcium regulation and protein phosphorylation. 
The concept of second messenger regulation of protein 
phosphorylation was thus well established prior to the 
discovery of Src and tyrosine phosphorylation.
Protein kinase discovery and disease. For the first 
two decades kinase discovery was driven by physiology 
and pharmacology and was built in large part on the pio-
neering work of Carl and Gertie Cori (29). How do hor-
mones and neurotransmitters control glycogen and glu-
cose metabolism? Although we did not appreciate this at 
the time, defects in the regulation of glycogen and glucose 
metabolism are the fundamental issues that define diabe-
tes. In response to glucagon, for example, PKA repro-
grams the entire metabolic profile of a cell such as the 
liver turning off glycolysis and turning on gluconeogen-
esis. Later the insulin receptor was found to also be a 
protein kinase (8), and this was followed by Akt (PKB) 
(30-32) and AMPK (33). All reinforce the importance of 
dynamic protein phosphorylation as one of the funda-
mental challenges for physiology and metabolism and one 
of the most important questions for diabetes, which has 
become an epidemic in this country. Diabetes kills more 
people than cancer and the long-term health problems 
associated with diabetes drive a major segment of our 
health care costs today.
The discovery of vSrc and the recognition that it was a 
protein kinase in 1979 opened an entirely new branch of 
the yet-to-be-discovered kinome (34). It immediately 
folded oncogenes and cancer into the kinome and enor-
mously expanded the relevance of protein phosphoryla-
tion for regulating biological processes. The discovery and 
characterization of Src also expanded the substrates to 
include tyrosine as well as serine and threonine (35). Fi-
nally the discovery that vSrc was a kinase and even more 
importantly the cloning of vSrc allowed us to go from 
individual gene products to genes and within two decades 
to the entire genome where we could then begin to map 
disease mutations.
Defining the active site. To define the protein kinase 
active site in advance of sequencing and before the struc-
ture was solved we return to PKA and classical protein 
chemistry. It was a relatively small protein kinase that 
could be purified from tissues in reasonable amounts. 
Recombinant proteins were still in the future. Affinity 
chromatography was used initially to define essential 
residues at the active site. Fluorosulfonyl benozoyl ade-
nosine (FSBA), an ATP analog that was first synthesized 
as an affinity probe by Coleman (36, 37), proved to be 
an excellent inhibitor of the C-subunit. Zoller showed 
that ATP protected against covalent modification and 
that a single lysine was modified (38, 39) (Figure 1). 
When the C-subunit was sequenced two years later, 
Lys72 was identified as being an essential part of the ATP 
binding site. Using a hydrophobic carbodiimide, dicyclo-
hexyl carbodiimide (DCCD), Buechler later showed in 
1983 that Lys72 could be easily cross-linked to Asp 184 
(40) (Figure 1). He also identified Glu91 as another acid-
ic residue that was close to the ATP binding site (41). Like 
FSBA, modification of Asp184 and Glu91, was protected 
in the presence of ATP so all of these residues were pre-
dicted to be at the active site near the site of catalysis. 
Site-directed mutagenesis was evolving in the laboratory 
of Mike Smith in Vancouver and when Zoller went there 
as a postdoctoral fellow he collaborated with Pawson to 
carry out one of the first site directed mutagenesis ex-
periments in an EPK. Because the members of the non-
receptors tyrosine kinases were rapidly cloned and se-
quenced, it was possible to identify in Fps the lysine that 
corresponded to Lys72 in PKA and change it to Ala. This 
kinase was inactive, thereby proving not only that the 
lysine was conserved but also establishing independently 
that it was essential for activity (42). Kamps and Sefton 
carried out the same experiment with Src (43), and K72 
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quickly became the key residue to modify in order to 
prove that a new kinase was, in fact, a bona fide kinase 
whose activity was essential for phosphorylation.
Constructing the kinome. While PKA was the second 
protein kinase to be discovered, in many ways it has been 
the prototypical kinase that paved the way for understand-
ing the structure and function of all members of the pro-
tein kinase superfamily. It was the first to be sequenced 
(44), and this laid the foundation for constructing the ki-
nome. Although a handful of protein kinases were discov-
ered in the two decades that followed the discovery of 
PhosK, it was not possible to build the kinome without 
sequence information. The sequence defined the chemical 
and genetic blueprint of the EPKs (1981) and also ushered 
the protein kinases into the world of chemistry. The early 
sequences of PKA, PKG (45), PhosK (46), and MLCK 
(47), led by Takio, Walsh and Titani in Seattle, were all 
done using the laborious classic techniques of protein se-
quencing that were elucidated in the 1950’s by Fred Sanger. 
The first protein to be sequenced by Sanger and for which 
he received his first Nobel Prize was, in fact, insulin (48) 
so once again we can see how basic physiology of glycogen 
and glucose metabolism drove the early biochemistry and 
protein chemistry. Once PKA was sequenced, Dayhoff im-
mediately recognized (Figure 1) that the sequence was re-
lated to the sequence of the recently cloned vSrc from Rous 
Sacoma Virus (49), which was reported to have kinase activ-
ity (34). This immediately defined the boundaries of the 
EPKs to include the tyrosine kinases. Cellular Src and Abl 
were both cloned in 1983, and the advances in cloning 
technologies then launched an exponential phase in the 
growth of the EPK superfamily. It also introduced cancer 
as a major disease target for regulation by protein kinases, 
and the EPKs have now become a major therapeutic target 
just beneath G-protein coupled receptors.
In 1988, in the „pre-BLAST” era, using just a handful 
of EPKs that were mostly sequenced from cloning, Hanks 
and Hunter aligned the sequences and identified twelve 
subdomains that still quite accurately reflect the con-
served motifs that are scattered throughout the conserved 
protein kinase core (Figure 1) (50). In today’s world of 
genome sequences, we have thousands of protein kinase 
sequences aligned and disease mutations are also being 
revealed at a phenomenal rate (51). In many ways this has 
provided the foundation for personalized medicine since 
we can now rapidly determine which particular mutation 
in which particular kinase drives the cancer in an indi-
vidual patient. ProKinO where the all of the kinases are 
aligned on the basis of structure as well as sequence is an 
especially valuable resource that allows us to query this 
family in ways that we never even dreamed of in the first 
three decades when the kinase world was unfolding (52).
Protein Kinase Structure. Twenty five years ago in 
1991 the structure of the PKA catalytic subunit was pub-
lished (Figure 2) (53, 54). It was first protein kinase 
structure to be solved, and it immediately gave func-
tional context to the conserved sequence motifs. It took 
us from a one-dimensional sequence-based tree to a 
three-dimensional template. What did we learn from 
that first structure (Figure 2)? This structure defined the 
conserved bi-lobal core that is shared by all EPKs with 
an N-lobe that was mostly beta structure and a C-lobe 
Figure 1. Defining a protein kinase. While initially a protein kinase was identified as a purified protein with biological activity, to chemi-
cally classify the protein kinases and to define the active site required classic protein chemistry. A. The ATP binding site was first identified by 
affinity labeling with fluorosulfonylbenzyl adenosine (FSBA), which labeled a single lysine residue [38, 39]. B. Sequence of the PKA C-subunit 
aligned with vSrc provided the chemical and genetic description of all EPKs [49]. Alignment of multiple EPKs allowed for the identification of 
conserved subdomains that are color coded [50]. C. The active site was further defined by chemical labeling with a hydrophobic carbo-diimide, 
dicylohexyl cardoiimide (DCCD), which labeled two carboxylic acid residues, Asp184 and Glu91 and cross-linked Asp184 to Lys72 [40, 41].
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that was mostly helical. It showed how the conserved 
motifs mostly cluster around the active site cleft, and it 
gave structural and functional significance to the subdo-
mains that were originally defined exclusively on the 
basis of sequence alignments. The motifs based on their 
primary sequence could now be translated into second-
ary and tertiary structural elements (Figure 3) (55). The 
structure also placed K72, D184, and E91 all in close 
proximity at the edge of the active site cleft and thus 
completely validated the earlier affinity labeling experi-
ments (Figure 2).
Although it was not emphasized at the time, how the 
adenine ring of ATP docked into the active site cleft (56) 
Figure 2. Protein kinase structure. The first protein kinase structure of the PKA C-subunit in 1991 moved the EPKs from a linear sequence-
defined family to a three dimensional template. A. The active site of the protein kinase confirmed the affinity labeling and gave functional sig-
nificance to the subdomains defined by the sequence alignment. B. The structure of the PKA C-subunit described the protein kinase fold [53, 
54], and this structure, combined with the subsequent ATP bound structure [56], defined the active site and allowed us to understand the 
functional roles of the conserved residues (white dots) that mostly clustered around the active site. It also showed how an inhibitor peptide (IP20, 
yellow) was docked into the active site cleft. Finally it showed how phosphorylation sites (blue dots) contributed to folding and activation. C. 
Phosphorylation of the Activation Loop on Thr197 contributes to the assembly of the active site. It serves as a nucleation site that integrates 
multiple subdomains that then reach across the entire molecule.
Figure 3. Defining the subdomains. Once the structure was solved, the subdomains were given functional significance. A. Subdomain I serves 
to cap the adenine ring of ATP, and Val57 is now recognized to be highly conserved as one of the N-lobe capping residues. B. The color-coded 
subdomains are mapped here onto the tertiary structure of the C-subunit [55]. C. Subdomain II contains the active site lysine, Lys72, as well as 
the highly conserved Ala70 which is the other N-lobe capping residue for ATP. The LSP alignment graphs for Subdomains I and II are shown 
at the bottom of panels A and C and the sequence conservation is shown at the top.
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defined an unusual mechanism for ATP binding that 
contrasted with previous catalytic kinases such as hexo-
kinase. A distinguishing feature of the EPKs is a Glycine-
rich Loop (G-Loop) that lies between the first two beta 
strands. This is quite distinct from the P-Loop or Walker 
Motif that is found in hexokinase and other ATPases, 
where the g-phosphate of ATP is buried under the P-Loop 
at the base of the cleft that lies between the two lobes (57). 
In the EPKs the adenine ring of ATP is buried under the 
G-Loop at the base of the cleft between the N-Lobe and 
the C-lobe while the g-phosphate is positioned at the edge 
of the cleft and is more solvent exposed. It is here where 
K72 and Glu91 from the N-lobe and Asp184 in the C-
Lobe converge in a highly dynamic way to position the 
g-phosphate of ATP and two metal ions (56). This site 
defines the essential heart of every EPK although with this 
first structure we did not appreciate how difficult it would 
be to trap a kinase in a fully closed conformation nor did 
we appreciate the full importance of the second metal ion 
(58). The dynamic G-Loop is a defining feature of the 
EPKs.
What else did we learn from that first structure? This 
was a fully active protein kinase that was phosphorylated 
on its Activation Loop (AL). We also did not appreciate 
at the time how unusual this was; however, it showed how 
a single phosphate on the Activation Loop integrated all 
parts of the molecule. Figure 2 shows how this single 
phosphate serves as a nucleation site for integrating many 
of the subdomains. Without this phosphate the C-subunit 
is very inactive (59) and only recently have we shown that 
the Activation Loop in the PKA C-subunit, as well as the 
C-tail, is disordered when the phosphate is missing (60). 
Although we now have many EPK structures, in most 
cases the kinase domain is cleaved from the rest of the 
protein and typically the Activation Loop is partially or 
fully disordered (61, 62). From this first structure of an 
active PKA C-subunit we did not appreciate the extreme-
ly dynamic properties of the Activation Loop. The AL is 
another feature that distinguishes the EPKs from their 
evolutionary precursors, the Eukaryotic-like kinases 
(ELKs). Subsequent comparisons of ELK’s and EPKs 
showed how the highly regulated Activation Loop and 
the aG-aI helical subdomain, linked by the Arg280-
Glu208 ion pair, are unique to the EPKs and highlight 
the complexity of regulation that has become the hall-
mark feature that defines the evolution of the EPKs (12, 
13, 63).
The original PKA structure also had a high affinity 
inhibitor peptide bound to the active site cleft. We also 
did not appreciate how unusual this was nor did we fully 
appreciate the nature of intrinsically disordered proteins 
and peptides that have docking sites and intrinsically dis-
ordered regions that only become ordered upon binding 
to the kinase. PKI is a heat stable protein kinase inhibitor 
that was discovered by Walsh initially as a contaminant 
of the catalytic subunit during purification (64). Exten-
sive peptide mapping of PKI showed how important the 
amphipathic helix is for enhancing high affinity binding 
(65, 66). This helix, which is actually stable in solution 
(67), docks onto the C-lobe and positions the intrinsi-
cally disordered region that contains the phosphorylation 
site precisely at the active site cleft. PKI is a pseudo-sub-
strate, and Walsh also showed how there is synergistic 
high affinity binding of PKI and ATP (68). In the pres-
ence of IP20 the affinity for ATP is 60 nM while the Km 
for binding in catalysis is 25 mM. With ATP and IP20 we 
thus had a structure that in many ways resembled a clas-
sic „transition state”. At the time of these first structures 
we simply did not appreciate how unusual it was to have 
a substrate docked so perfectly into the active site cleft or 
to have the second magnesium ion ordered (69). Only 
later was PKI recognized to be a classic intrinsically dis-
ordered protein that has two well-defined helices in solu-
tion in contrast to the highly dynamic inhibitor site which 
only becomes ordered when it binds to the C-subunit (67, 
70).
Hydrophobic Spines. What did we not learn from 
this first structure? What did we miss? While we have 
learned a great deal about the protein kinase superfamily 
from PKA, to understand if there were some fundamental 
rules governing the activation of all protein kinases we 
needed to compare many kinases. By this time, recogniz-
ing the immense importance of the EPKs for disease, 
there were many protein kinase structures. For this com-
parison of active and inactive kinases a graph theory 
method, Local Spatial Pattern (LSP) alignment, was used 
where the spatial conservation of residues was combined 
with the conservation of their chemical properties. This 
comparison of the conserved core of active and inactive 
kinases revealed the simple but defining concept of a con-
served hydrophobic regulatory spine (R-spine) that was 
dynamically assembled in every active protein kinase (71) 
(Figure 4).
Although the R-spine is now recognized to be the hall-
mark signature of every active kinase, it was missed in the 
original analysis of motifs for several reasons. Our LSP 
alignment of active and inactive kinases relied on spatial 
conservation of residues not just on conserved sequence 
motifs. Although the R-spine residues are always hydro-
phobic, the sequences are not absolutely conserved (Figure 
4). While the precisely fixed interactions that are medi-
ated by electrostatic and hydrogen bonding partners can 
be captured in the sequence conservation alone, the more 
fluid positioning of the hydrophobic residues is harder to 
appreciate and identify. The R-spine is comprised of four 
hydrophobic residues, two in the C-lobe and two in the 
N-lobe. It is anchored to the aF-Helix by a conserved 
aspartic acid, Asp220, which was recognized in the orig-
inal sequence alignment. RS1 (Tyr164 in PKA) is part of 
the HRD motif that lies at the beginning of the Cata-
lytic Loop. Arg165 reaches to the Activation Loop phos-
phorylation site in those kinases that have a phosphoryla-
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tion site in their AL (Figure 2). Asp166 is the catalytic 
base that positions the P-site hydroxyl moiety in the sub-
strate. RS1 is either a His or a Tyr. RS2 (Phe185) is the 
DFG motif, and all three residues are highly conserved. 
Asp184 binds to the second metal ion, and, as indicated 
above, Asp184 cross-linked to Lys72 in the early affinity 
labeling experiments. RS3 and RS4 in the N-lobe are 
more variable but are often Val or Leu. RS3 is in the aC-
helix and lies one turn beyond Asp91, which also interacts 
with K72. RS4 begins the b5 strand. The aC-b4 loop is 
a highly conserved motif that was also not appreciated at 
all in the original structure but is a defining element of 
every protein kinase. The functional importance of the 
R-spine and the ways in which mutations can generate a 
constitutively active kinase were validated in BCR-Abl 
(72) and BRaf (73-75), which is one of the most com-
monly mutated kinases in cancer.
Further analysis of the conserved hydrophobic residues 
revealed a second spine, which is referred to as the cata-
lytic spine or C-Spine (76). The C-spine is assembled by 
the binding of ATP, in particular by the adenine ring, 
which is wedged between Ala70 and Val57 in the N-lobe 
and Leu173 in the b7 strand of the C-lobe (Figure 4A). 
By reaching across the Catalytic Loop the binding of the 
adenine ring assembles the active site and in particular the 
three regulatory residues identified by affinity labeling, 
Lys72, Asp184 and Glu91. Both spines are anchored to 
the hydrophobic aF-Helix, which spans the C-lobe. It is 
very unusual to have a hydrophobic helix such as this 
buried in a globular protein. Most helices in globular pro-
teins are amphipathic. The aF-Helix has a conserved Gly 
in the middle, and it is split into two functional units 
when the C-subunit is subjected to a Community Map 
analysis (77). If we look at Val57 and Ala70 in the se-
quence alignments, they both are as conserved as K72 and 
E91, but their functional significance was overlooked un-
til the LSP alignment (78, 79) showed that they were also 
spatially conserved (Figures 3A and 3C).
A closer look at Subdomains I and II reveals some of 
the key residues that we glossed over in the initial motif 
analysis. Val57, for example, is in Subdomain I along with 
the G-loop (Figure 3A), and it precisely defines why the 
G-loop is different from a P-Loop. Beta strands 1 and 2 
sequester the adenine ring of ATP while the P-Loop se-
questers the g-phosphate. Ala70 lies in Subdomain II in 
the b3 strand two residues before K72. As seen in Figure 
3, the Ala is very highly conserved but its essential func-
tional role was not appreciated until its spatial position 
relative to the C-spine was considered. The same is true 
for Val57 (Figure 3C). We simply did not appreciate its 
conservation and its functional significance in the initial 
alignment. These two residues, Ala70 and Val57, describe 
the capping motif in the N-lobe. Leu173 in the C-lobe 
lies in the b7 strand that follows the catalytic loop and 
provides the C-lobe cap for the adenine ring (Figure 2A).
Opening and closing of the catalytic cleft. Once the 
active kinase is assembled it must traverse through its 
catalytic cycle. In the case of PKA, by converting the IP20 
peptide from PKI into a substrate (SP20), almost every 
step of the catalytic cycle has been trapped in a crystal 
lattice so we have a good static chemical definition of each 
step (80, 81). Kinase activity is typically determined with 
small peptides such as Kemptide (Leu-Arg-Arg-Ala-Ser-
Leu-Gly) using Michaelis Menten conditions, and under 
Figure 4. Hydrophobic spines define the underlying architecture of the EPK family. A. The essential elements of the hydrophobic spine 
architecture include the R-spine and the C-spine which are both anchored to the aF-Helix [78]. B. The C-spine is completed by the binding of 
ATP where the adenine ring is capped by Ala70 and Val57 in the N-lobe and Leu173 in the C-lobe. C. The catalytic loop is anchored to both 
the C-spine and the R-spine and the aF-Helix. The adenine ring of ATP is anchored to the C-Spine while the g-phosphate is anchored through 
the regulatory triad (Lys72, Glu91, and Asp184) to the R-spine. D. The conserved R-spine that is dynamically assembled in every active kinase 
includes two residues from the C-Lobe (Tyr164 from the HRD motif and Phe185 from the DFG motif) and two residues from the N-Lobe 
(Leu95 from the aC Helix and Leu106 from the b3 strand)
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these conditions the phosphorylated peptide is rapidly 
released leaving release of the metal bound nucleotide as 
the rate-limiting step (82). For PKA the critical step for 
release of the nucleotide is the release of the first metal ion 
that is bound to Asp184 (81, 83). In addition, the hinge 
and twist motions that are associated with opening and 
closing of the catalytic cleft (84) do not require breaking 
of either spine.
As discussed above, in contrast to ATPases and meta-
bolic enzymes such as hexokinase, the G-loop in the EPKs 
traps the adenine ring at the base of the cleft which com-
pletes the C-spine and leaves the g-phosphate to be trans-
ferred at the edge of the cleft. Protein and peptide sub-
strates are then positioned mostly by the C-lobe to accept 
the phosphate. The motions associated with binding of 
substrates and transferring the phosphate have not only 
been trapped with SP20 in crystal structures but also have 
been carefully described by NMR where one can appreci-
ate both the side chain and backbone dynamics of every 
residue (85, 86). To understand opening and closing of 
the active site cleft, however, we return to the fully closed 
conformation where the g-phosphate is trapped between 
the two lobes by the triad that was described by the early 
affinity labeling. We know, for example, from Ala scan-
ning mutagenesis that both Lys72 and Glu91 are essential 
for efficient steady state catalysis (87). However, even 
though both mutants are deficient in steady state catalysis 
they can both still bind ATP with affinities that are sim-
ilar to the wt C-subunit once the Activation Loop is phos-
phorylated (88, 89). In the case of the Glu91Ala mutant, 
catalytic activity can be rescued by strengthening the R-
spine or by removing a key His in the aC-Helix that helps 
to anchor the aC-Helix in a closed conformation (89) (see 
Figure 2C). These results suggest that the conserved ion 
pair is more important for synchronizing the opening and 
closing of the two lobes rather than for simply the binding 
of ATP. This node (Lys72, Glu91, D184) can thus be 
thought of as a highly conserved „regulatory triad” that 
is essential for the regulation of every protein kinase in 
contrast to the catalytic triad that is conserved in prote-
ases. Three motifs, each containing a spine residue, de-
liver these residues to the active site cleft. The b3 strand 
containing Lys72 is the defining conserved motif of Sub-
domain II and is anchored to the ATP binding site by 
Ala70. Glu91 lies in the aC Helix, which is core con-
served element of Subdomain III and is positioned by 
Leu95, an essential R-spine residue in the N-Lobe. Asp184 
in the C-lobe is positioned by Phe185 which is another 
R-spine residue in the DFG motif (Subdomain VII). Em-
bedded within this triad are all the essential features of 
the EPK superfamily.
Assembly of the active Catalytic Subunit. The PKA 
C-subunit was also the first protein kinase to be expressed 
in E. coli (90), and the recombinant protein is fully active 
and phosphorylated. It contains two stable phosphates, 
Thr197 on the Activation Loop (AL) and Ser338 on the 
C-terminal Tail (C-Tail) (Figure 2C). Unlike many pro-
tein kinases, perhaps most, these two phosphates in the 
PKA C-subunit are quite stable. The role of the AL phos-
phate was discussed earlier; it is a conserved feature of 
most protein kinases, and, in many cases, assembly of the 
R-spine is coordinated with AL phosphorylation (60). The 
C-Tail, however, even though it lies outside the conserved 
core, is still an essential part of the active kinase. The N- 
and C-terminal linkers of all protein kinases contribute 
in very significant ways to activation and regulation. The 
C-Tail of the C-subunit wraps around both lobes of the 
conserved core and is essential for ATP binding and ca-
talysis (91, 92) (Figure 5). It is actually a highly conserved 
feature of all AGC kinases (93), and its dynamic regula-
tion by phosphorylation is finely tuned in different ways 
for each AGC kinase (Figure 5). In the PKA C-subunit 
the C-tail phosphate is added as part of the maturation 
process while the C-subunit is still on the ribosome, 
Figure 5. The tails of PKA. The conserved kinase core of the PKA C-subunit is embraced by two tails that each wrap around both lobes of the 
core. The N-terminal tail (residues 1-39) is myristylated while the C-terminal tail (residues 301-350) is phosphorylated on Ser 338. A. The 
motifs of the C-tail include Phe327 which is an essential part of the ATP binding site [92, 128], a phosphorylation site at Ser338, and a hy-
drophobic motif that is anchored to the aC-Helix. B. The C-Tail wraps around both lobes of the kinase core (N-lobe in white and C-lobe in 
tan). C. The C-Tail is a conserved feature of all AGC kinases [93]. D. The myristylated N-tail also wraps around both lobes of the core and is 
dominated by the aA-Helix (yellow balls correspond to the myristyl moiety) [129, 130].
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whereas the AL phosphate is likely added post-transla-
tionally either by a trans-auto-phosphorylation mecha-
nism that is mediated by another C-subunit or by cis-
phosphorylation that is mediated by the heterologous 
kinase, PDK1, which is the major activator of most AGC 
kinases (94). In contrast, the C-Tail phosphorylation ap-
pears to be mediated by a non-canonical cis-auto-phos-
phorylation mechanism in the process of folding (95). In 
contrast to most other kinases where these phosphates 
turnover rapidly, in PKA these phosphates are extremely 
resistant to removal by phosphatases (95). The important 
point for PKA is that it is synthesized as a very stable 
phosphorylated protein and then packaged with cAMP 
binding regulatory subunits so that its activation is depen-
dent on cAMP, not on the dynamic turnover of the Acti-
vation Loop phosphate. To understand PKA signaling in 
cells it is thus necessary to understand both the R-sub-
units as well as the full length anchored holoenzymes.
Regulatory subunits. In mammalian cells there are 
four functionally non-redundant dimeric regulatory (R) 
subunits (RIa, RIb, RIIa, and RIIb), and PKA specific-
ity is achieved largely by the isoform diversity of the R-
subunits and their targeting to specific sites in the cell by 
scaffold proteins referred to as A Kinase Anchoring Pro-
teins (AKAPs). Each chain of the R-subunit dimer binds 
to one C-subunit creating an inactive R2C2 holoenzyme. 
All of the R-subunits have a conserved domain organiza-
tion with a helical dimerization/docking (D/D) domain 
at the N-terminus that also serves as the docking site for 
AKAPs. The D/D domain is joined by a flexible linker to 
two tandem cyclic nucleotide binding (CNB) domains 
(CNB-A and CNB-B). Embedded within each linker is 
an Inhibitor Site (IS) that docks into the active site cleft 
of the C-subunit in the holoenzyme and prevents binding 
of other substrates. Like PKI the RI subunits are pseudo-
substrates; the P-site in the IS is replaced with Gly or Ala. 
C-subunits bound to both PKI and R-subunits bind ATP 
with high affinity (60 nM) when two metal ions are pres-
ent (69, 96, 97). The synergistic high affinity binding of 
RI subunits and ATP is thus a conserved feature of the 
RI subunits and PKI. In contrast, the RII subunits are 
also substrates; the P-site is a Ser.
Sequencing of the RIa and RIIa subunits showed that 
the CNB domains were related to the CNB domains of 
the catabolite gene activator protein (CAP) in E. coli so 
this domain has been conserved across all phyla as the 
domain that translates the cAMP second messenger sig-
nal into a biological response (98-100). Initially, and in 
advance of a crystal structure, affinity labeling with a 
photo-activatable cAMP analog, 8-N3-cAMP was used 
to define the active site (101, 102). A conserved tyrosine 
was identified in the CNB-B domains of both RIa and 
RIIb (Figure 6B) while Trp260 was identified as a part of 
the cAMP-binding site in the CNB-A domain of RIa 
(Figure 6A). The structural conservation of the PKA R-
subunits and CAP was confirmed by the crystal structure 
Figure 6. Cyclic nucleotide binding domain. The conserved features of the CNB domain were first defined by aligning the sequences of CAP 
and the RIa subunit [100]. Capping residues for the adenine ring were identified by affinity labeling. Structures allowed us to define the mo-
lecular features of the domain and the detailed features of the cAMP binding site. Affinity labeling of RIa with 8-N3-cAMPidentified two sites 
of modification, Trp260 and Tyr371. A. The capping of cAMP bound to CNB-A is shown as well as a cartoon correlating the a and b struc-
tural elements with the sequence. The PBC (shown in red) defines the hallmark motif of each CNB domain and contains a conserved arginine 
that binds to the phosphate moiety of cAMP. B. Cyclic AMP bond to the CNB-B domain is capped by a highly conserved tyrosine, Tyr371 in 
RIa. C. Overlaid CNB-domains of RIa and CAP.
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of a monomeric form of RIa (103), while the subsequent 
structure of cAMP bound to a monomeric form of RIIb 
(104) revealed the conserved fold of each domain but a 
distinct allosteric coupling between the two domains. 
These structures also showed that the Inhibitor Site, al-
though present, was disordered in the absence of the C-
subunit. These structures and their comparison to CAP 
allowed Berman to build a conserved allosteric framework 
for cAMP binding (Figure 6C) including the capping 
residues that were identified by the affinity labeling (105, 
106). The conserved signature motif of every CNB do-
main, however, is a Phosphate Binding Cassette (PBC). 
The conservation of the PBC, and in particular a con-
served arginine, was clear from the sequence conservation 
and from an early genetic screen for cAMP resistance that 
was carried out in the 1970’s in mouse lymphoma cells 
(107, 108), but its functional significance as the key resi-
due that binds to the phosphate of cAMP was only re-
vealed by the structures. While we learned much about 
the cAMP binding features of the R-subunits and about 
their evolution from these crystal structures, they did not 
explain how the C-subunit was inhibited nor did they 
explain the highly allosteric activation of the holoenzyme 
by cAMP. This required structures of R:C complexes.
Functional and structural non-redundancy of the 
holoenzymes. Crystallizing R:C complexes showed how 
the activity of the catalytic subunit was inhibited by dock-
ing of the IS into the active site cleft. This we predicted 
but did not actually „see” until the first structure of an 
RIa heterodimer was solved with an RIa that contained 
a single CNB domain (109). This structure, followed by 
a structure of a heterodimer of an RIa monomer that 
contained two CNB domains (110), confirmed that sig-
nificant conformational changes occur when cAMP is 
released and the C-subunit is bound. These structures also 
allowed us to define the allosteric motions of the subdo-
mains in each CNB domain (105, 106). However, these 
R:C complexes, as well as subsequent R:C complexes with 
RIIa (111), still did not explain the functional non-redun-
dancy of the R-subunits nor did they explain allosteric 
activation. For this we needed to solve structures of full-
length holoenzymes.
Only in the R2C2 holoenzymes can one appreciate the 
symmetry of PKA and the allosteric features that control 
activation by cAMP. Our first glimpse of this symmetry 
came with an RIa:C heterodimer with an extended N-
Linker that preceded the IS. This crystallized as a dimer of 
dimers and allowed us to build our first model of an R2C2 
holoenzyme for RIa that is fully consistent with all of our 
small angle X-ray and neutron scattering (SAXS/SANS) 
(112). Structures of the RIIb holoenzyme (113) and then 
the RIb holoenzyme (114) showed the striking symmetry 
that is achieved. At the same time these structures also 
explained how the structural constraints of one heterodi-
mer on the other heterodimer leads to a highly allosteric 
mechanism for activation. The holoenzyme structure also 
helps to explain why the Hill Coefficient for activation of 
the heterodimeric RIIb:C complex is 1.0 in contrast to 1.8 
for the R2C2 RIIb holoenzyme (113). Furthermore these 
three isoform holoenzyme structures (RIIb, RIb, and the 
RIa model) show distinct quaternary structures. This was 
suggested by early SAXS and SANS studies of the native 
holoenzymes in solution (115, 116), but confirmed in the 
crystal structures. The holoenzymes are structurally dis-
tinct as well as functionally distinct (117).
Targeted PKA Scaffolds create Signalosomes. The 
specificity of PKA signaling does not end, however, with 
the structures of the full-length holoenzymes. These ho-
loenzymes are in turn each targeted to specific sites in the 
cell, usually by AKAPs. In this way the cell creates nodes 
of PKA signaling that are dedicated to the phosphoryla-
tion of specific residues that are typically linked to chan-
nel or transporter opening or receptor internalization. The 
signature motif of every AKAP (Figure 9) is an amphipa-
thic helix that binds with high affinity (1-40 nM) to the 
Figure 7. PKA activity is controlled by binding to regulatory subunits. To understand how PKA activity is regulated by cAMP it was 
necessary to solve structures of complexes between the R- and C-subunits. Initial complexes between monomeric forms of RIa showed how the 
activity of the C-subunit was inhibited and how the R-subunit underwent conformational changes as it released cAMP and wrapped around 
the C-lobe of the C-subunit.
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N-terminal D/D domain of the R-subunit (118-120). 
Each AKAP thus recruits PKA, along with other signal-
ing proteins such as phosphatases, phosphodiesterases, 
and other kinases, to a highly dynamic polyvalent sig-
nalosome.
While most AKAPs are specific for RII subunit, some 
are dual specific and bind to both RI and RII (121, 122). 
Others are highly specific for RI (123) while a few such 
as GPR161 have absolute specificity for RI-subunits. 
GPR161, which is the cilia-related G-protein coupled re-
ceptor, is also unusual in that the AKAP motif is actu-
ally embedded within the C-terminal tail of the receptor 
(124). DAKAP2 is dual specific AKAP that in the kidney 
is localized to the proximal kidney tubules and couples 
through its C-terminal PDZ motif to PDZ-K1, a multi-
PDZ domain protein that binds to transporters such as 
the Na+/PO3
– transporter (Figure 9). The way in which 
the RIa D/D domain couples to the amphipathic helix 
of DAKAP2 is shown on the Figure 9A while the way in 
which the AKAP nucleates interactions between three 
proteins is shown on Figure 9C (120, 125-127).
Remaining Challenges and Opportunities. Our 
ultimate challenge for PKA signaling is to understand 
how these dynamic signalosomes toggle between their 
active and inactive states to regulate processes such as 
channel or transporter opening. It is a challenge that will 
require a highly interdisciplinary approach that spans 
many scales. While crystal structures capture stable stat-
ic states at high resolution, they do not capture the dy-
namic features of regulation. NMR can provide essential 
data on protein and side chain dynamics; however, it will 
ultimately be essential to observe these processes in live 
cells. Cryo Electron Microscopy and live cell imaging will 
be essential to achieve this goal. While we have achieved 
much over these past 25 years, in many ways we are just 
beginning to understand the sophisticated and highly 
Figure 8. Structural diversity of the PKA holoenzymes. Only with the R2C2 holoenzymes can we appreciate the functional and structural 
diversity of the PKA regulatory subunits. The quaternary structures of each holoenzyme are distinct and help to explain their functional non-
redundancy.
Figure 9. Signalosomes and scaffolds. Each PKA holoenzyme is targeted to specific sites in the cell by scaffold proteins such as the AKAPs. DA-
KAP2 (or AKAP 11) was identified as a dual specific AKAP that bound to both RI and RII subunits [122]. An amphipathic helix that defines 
the A Kinase Binding motif (AKB) and is the hallmark signature of every AKAP, this helix binds with high affinity to the helical D/D domain of 
the R-subunit. A. The AKB of DAKAP2 docked onto the D/D domain of RIa [126]. B. DAKAP2 nucleates a polyvalent complex between PDZ-
K1 and various transporters and is also bound to Rab4 and Rab11 and contributes to vesicle trafficking [125]. C. Structure of the DAKAP2 AKB 
bound to both the D/D domain of RIIa and the PDZ domain of PDZ-K1 shows how the AKAP nucleates a polyvalent complex [127].
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dynamic mechanisms that mediate regulation by protein 
phosphorylation. The fundamental importance of this 
challenge is amplified by the many diseases that are now 
recognized to be associated with dysfunctional protein 
kinases. In the case of PKA, for example, disease muta-
tions are associated with both regulatory and catalytic 
subunits, and the resulting phenotypes are cell and tissue 
specific. Increasingly these disease phenotypes will help 
to drive and enhance our understanding of normal PKA 
signaling.
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